Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-8 of 8
1-8 of 8
Filter
Jerome Julian Grove
Co-Founder at The Physician's Choice CBD
alprazolam, alternative medicine, amitriptyline, analgesic, anesthesia, antihypertensive drug, arthritis, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, cancer, cannabinoid, carisoprodol, chiropractic, complex regional pain syndrome, crohn's disease, cyclobenzaprine, depression (mood), diabetic neuropathy, diarrhea, diazepam, diclofenac, dose (biochemistry), entourage effect, fentanyl, forecoxa, gabapentin, gastrointestinal disease, general surgery, harm reduction, heroin, ibuprofen, ileostomy, inflammatory bowel disease, lorazepam, medical cannabis, medical prescription, medication, meloxicam, methadone, muscle relaxant, naproxen, opiate, opioid, opioid epidemic in the united states, opioid use disorder, over-the-counter drug, oxycodone/paracetamol, pain management, paracetamol, paresthesia, peripheral neuropathies, peripheral neuropathy, pharmacology, pregabalin, psychoactive drug, rheumatology, route of administration, substance dependence, systemic lupus erythematosus, tapenade, terminal illness, tetrahydrocannabinol, therapeutic index, tramadol, ulcerative colitis
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
William Fisher
Board Chairman at Diverse Biotech
appetite, aspirin, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), chemotherapy, clinical trial, dementia, dietary supplement, direct-to-consumer advertising, dose (biochemistry), drug development, endocannabinoid system, fibromyalgia, first, pass effect, food and drug administration, gastrointestinal tract, headache, hemp, in vitro, inflammation, intravenous therapy, micro-encapsulation, nanoparticle, nutraceutical, opioid epidemic in the united states, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, route of administration, sensitivity and specificity, steve jobs, synthetic cannabinoids, tetrahydrocannabinol, toxicity
Kristina Etter
Editorial Content Director at Cannabis Tech
alprazolam, analgesic, anesthesia, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, carisoprodol, chiropractic, diazepam, fentanyl, harm reduction, heroin, lorazepam, methadone, muscle relaxant, opiate, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, pain management, peripheral neuropathy, pregabalin, substance dependence
Christian Shaw
Christian Shaw at REBEL MD
alprazolam, analgesic, anesthesia, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, carisoprodol, chiropractic, diazepam, fentanyl, harm reduction, heroin, lorazepam, methadone, muscle relaxant, opiate, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, pain management, peripheral neuropathy, pregabalin, substance dependence
Dexter Russell
CEO at Naprapathic Health Solutions
alprazolam, analgesic, anesthesia, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, carisoprodol, chiropractic, diazepam, fentanyl, harm reduction, heroin, lorazepam, methadone, muscle relaxant, opiate, opioid, opioid epidemic in the united states, opioid use disorder, oxycodone/paracetamol, pain management, peripheral neuropathy, pregabalin, substance dependence
1
1-8 of 8